Konica Minolta announced on July 6 that it will acquire Ambry Genetics Corporation, a U.S.-based genetics testing company, for $1 billion, the largest acquisition ever for the Japanese technology giant. The transaction to buy Ambry will be partially funded by the Japanese government-backed Innovation Network Corporation of Japan (INCJ). Konica Minolta, through its U.S. healthcare
